STOCK TITAN

[8-K] FOXO Technologies Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Magnite, Inc. (MGNI) filed a Form 144 indicating a planned sale of 9,289 common shares worth approximately $204,358 at prevailing market prices. The shares were originally acquired on 02/15/2024 as restricted stock directly from the issuer and will be executed through Morgan Stanley Smith Barney LLC on or about 06/30/2025. Total shares outstanding are reported at 141,110,559, so the proposed sale represents less than 0.01 % of the float.

The filing lists David Buonasera as the selling shareholder, who has already disposed of 12,395 shares over the past three months for gross proceeds of $194,776.59. While the dollar amounts are modest relative to Magnite’s market capitalization, consecutive insider sales can raise sentiment concerns for some investors. The form contains no operational or financial performance data and makes no assertions about Magnite’s fundamentals; it solely discloses the insider’s intent to sell under Rule 144.

Magnite, Inc. (MGNI) ha presentato un modulo 144 che indica la vendita pianificata di 9.289 azioni ordinarie per un valore approssimativo di 204.358 $ ai prezzi di mercato correnti. Le azioni erano state originariamente acquisite il 15/02/2024 come azioni vincolate direttamente dall'emittente e la vendita sarà eseguita tramite Morgan Stanley Smith Barney LLC intorno al 30/06/2025. Il numero totale di azioni in circolazione è riportato essere 141.110.559, pertanto la vendita proposta rappresenta meno dello 0,01% del flottante.

Il modulo indica David Buonasera come azionista venditore, che negli ultimi tre mesi ha già ceduto 12.395 azioni per un ricavo lordo di 194.776,59 $. Sebbene gli importi in dollari siano modesti rispetto alla capitalizzazione di mercato di Magnite, vendite consecutive da parte di insider possono generare preoccupazioni tra alcuni investitori. Il modulo non contiene dati operativi o finanziari né affermazioni sui fondamentali di Magnite; si limita a dichiarare l'intenzione dell'insider di vendere secondo la Regola 144.

Magnite, Inc. (MGNI) presentó un Formulario 144 que indica una venta planificada de 9,289 acciones comunes por un valor aproximado de $204,358 al precio de mercado vigente. Las acciones fueron adquiridas originalmente el 15/02/2024 como acciones restringidas directamente del emisor y la venta se realizará a través de Morgan Stanley Smith Barney LLC alrededor del 30/06/2025. El total de acciones en circulación se reporta en 141,110,559, por lo que la venta propuesta representa menos del 0,01 % del flotante.

El formulario lista a David Buonasera como el accionista vendedor, quien ya ha vendido 12,395 acciones en los últimos tres meses por ingresos brutos de $194,776.59. Aunque los montos en dólares son modestos en relación con la capitalización de mercado de Magnite, ventas consecutivas de insiders pueden generar preocupaciones en algunos inversores. El formulario no contiene datos operativos ni financieros ni hace afirmaciones sobre los fundamentos de Magnite; únicamente revela la intención del insider de vender conforme a la Regla 144.

Magnite, Inc. (MGNI)는 9,289주의 보통주를 약 204,358달러 상당으로 매도할 계획임을 나타내는 Form 144를 제출했습니다. 해당 주식은 2024년 2월 15일에 발행사로부터 직접 제한 주식으로 취득되었으며, 2025년 6월 30일Morgan Stanley Smith Barney LLC를 통해 매각될 예정입니다. 총 발행 주식 수는 141,110,559주로 보고되어 이번 매도는 유통 주식의 0.01% 미만에 해당합니다.

해당 신고서에는 매도 주주로 David Buonasera가 명시되어 있으며, 그는 지난 3개월간 이미 12,395주를 매도해 총 194,776.59달러의 총수익을 올렸습니다. 금액은 Magnite의 시가총액에 비해 크지 않지만, 연속적인 내부자 매도는 일부 투자자들에게 우려를 불러일으킬 수 있습니다. 이 서류에는 운영 또는 재무 성과 데이터가 포함되어 있지 않으며 Magnite의 기본적인 재무 상태에 대한 언급도 없고, 단지 Rule 144에 따른 내부자의 매도 의도만을 공개합니다.

Magnite, Inc. (MGNI) a déposé un formulaire 144 indiquant une vente prévue de 9 289 actions ordinaires d'une valeur d'environ 204 358 $ aux prix du marché en vigueur. Les actions ont été initialement acquises le 15/02/2024 sous forme d'actions restreintes directement de l'émetteur et la vente sera réalisée via Morgan Stanley Smith Barney LLC aux alentours du 30/06/2025. Le nombre total d'actions en circulation est de 141 110 559, la vente proposée représentant donc moins de 0,01 % du flottant.

Le dépôt indique David Buonasera comme actionnaire vendeur, qui a déjà cédé 12 395 actions au cours des trois derniers mois pour un produit brut de 194 776,59 $. Bien que les montants en dollars soient modestes par rapport à la capitalisation boursière de Magnite, des ventes consécutives d'initiés peuvent susciter des inquiétudes chez certains investisseurs. Le formulaire ne contient aucune donnée opérationnelle ou financière et ne fait aucune déclaration sur les fondamentaux de Magnite ; il se limite à divulguer l'intention de l'initié de vendre conformément à la règle 144.

Magnite, Inc. (MGNI) hat ein Formular 144 eingereicht, das einen geplanten Verkauf von 9.289 Stammaktien im Wert von etwa 204.358 $ zum aktuellen Marktpreis anzeigt. Die Aktien wurden ursprünglich am 15.02.2024 als eingeschränkte Aktien direkt vom Emittenten erworben und sollen etwa am 30.06.2025 über Morgan Stanley Smith Barney LLC verkauft werden. Die Gesamtzahl der ausstehenden Aktien beträgt 141.110.559, sodass der geplante Verkauf weniger als 0,01 % des Streubesitzes ausmacht.

Im Formular wird David Buonasera als verkaufender Aktionär genannt, der in den letzten drei Monaten bereits 12.395 Aktien für einen Bruttoerlös von 194.776,59 $ veräußert hat. Obwohl die Dollarbeträge im Verhältnis zur Marktkapitalisierung von Magnite gering sind, können aufeinanderfolgende Insider-Verkäufe bei einigen Investoren Bedenken hervorrufen. Das Formular enthält keine operativen oder finanziellen Leistungsdaten und macht keine Aussagen zu den Fundamentaldaten von Magnite; es offenbart lediglich die Verkaufsabsicht des Insiders gemäß Regel 144.

Positive
  • None.
Negative
  • Insider continues to sell shares, potentially signaling reduced personal confidence although amounts are immaterial.

Insights

TL;DR: Small, routine Rule 144 sale; sentiment slightly negative but immaterial financially.

The transaction involves 9,289 shares, following two earlier sales in May totaling 12,395 shares. Cumulatively, the insider will have sold about 21,684 shares—still an insignificant fraction of Magnite’s ~141 million shares outstanding. Because no additional context (e.g., option expirations, tax obligations) is provided, investors may view the pattern as mild bearish sentiment from the insider. However, the dollar value is too small to affect liquidity or ownership structure. I classify the filing as not impactful for valuation, but worth noting in governance tracking.

Magnite, Inc. (MGNI) ha presentato un modulo 144 che indica la vendita pianificata di 9.289 azioni ordinarie per un valore approssimativo di 204.358 $ ai prezzi di mercato correnti. Le azioni erano state originariamente acquisite il 15/02/2024 come azioni vincolate direttamente dall'emittente e la vendita sarà eseguita tramite Morgan Stanley Smith Barney LLC intorno al 30/06/2025. Il numero totale di azioni in circolazione è riportato essere 141.110.559, pertanto la vendita proposta rappresenta meno dello 0,01% del flottante.

Il modulo indica David Buonasera come azionista venditore, che negli ultimi tre mesi ha già ceduto 12.395 azioni per un ricavo lordo di 194.776,59 $. Sebbene gli importi in dollari siano modesti rispetto alla capitalizzazione di mercato di Magnite, vendite consecutive da parte di insider possono generare preoccupazioni tra alcuni investitori. Il modulo non contiene dati operativi o finanziari né affermazioni sui fondamentali di Magnite; si limita a dichiarare l'intenzione dell'insider di vendere secondo la Regola 144.

Magnite, Inc. (MGNI) presentó un Formulario 144 que indica una venta planificada de 9,289 acciones comunes por un valor aproximado de $204,358 al precio de mercado vigente. Las acciones fueron adquiridas originalmente el 15/02/2024 como acciones restringidas directamente del emisor y la venta se realizará a través de Morgan Stanley Smith Barney LLC alrededor del 30/06/2025. El total de acciones en circulación se reporta en 141,110,559, por lo que la venta propuesta representa menos del 0,01 % del flotante.

El formulario lista a David Buonasera como el accionista vendedor, quien ya ha vendido 12,395 acciones en los últimos tres meses por ingresos brutos de $194,776.59. Aunque los montos en dólares son modestos en relación con la capitalización de mercado de Magnite, ventas consecutivas de insiders pueden generar preocupaciones en algunos inversores. El formulario no contiene datos operativos ni financieros ni hace afirmaciones sobre los fundamentos de Magnite; únicamente revela la intención del insider de vender conforme a la Regla 144.

Magnite, Inc. (MGNI)는 9,289주의 보통주를 약 204,358달러 상당으로 매도할 계획임을 나타내는 Form 144를 제출했습니다. 해당 주식은 2024년 2월 15일에 발행사로부터 직접 제한 주식으로 취득되었으며, 2025년 6월 30일Morgan Stanley Smith Barney LLC를 통해 매각될 예정입니다. 총 발행 주식 수는 141,110,559주로 보고되어 이번 매도는 유통 주식의 0.01% 미만에 해당합니다.

해당 신고서에는 매도 주주로 David Buonasera가 명시되어 있으며, 그는 지난 3개월간 이미 12,395주를 매도해 총 194,776.59달러의 총수익을 올렸습니다. 금액은 Magnite의 시가총액에 비해 크지 않지만, 연속적인 내부자 매도는 일부 투자자들에게 우려를 불러일으킬 수 있습니다. 이 서류에는 운영 또는 재무 성과 데이터가 포함되어 있지 않으며 Magnite의 기본적인 재무 상태에 대한 언급도 없고, 단지 Rule 144에 따른 내부자의 매도 의도만을 공개합니다.

Magnite, Inc. (MGNI) a déposé un formulaire 144 indiquant une vente prévue de 9 289 actions ordinaires d'une valeur d'environ 204 358 $ aux prix du marché en vigueur. Les actions ont été initialement acquises le 15/02/2024 sous forme d'actions restreintes directement de l'émetteur et la vente sera réalisée via Morgan Stanley Smith Barney LLC aux alentours du 30/06/2025. Le nombre total d'actions en circulation est de 141 110 559, la vente proposée représentant donc moins de 0,01 % du flottant.

Le dépôt indique David Buonasera comme actionnaire vendeur, qui a déjà cédé 12 395 actions au cours des trois derniers mois pour un produit brut de 194 776,59 $. Bien que les montants en dollars soient modestes par rapport à la capitalisation boursière de Magnite, des ventes consécutives d'initiés peuvent susciter des inquiétudes chez certains investisseurs. Le formulaire ne contient aucune donnée opérationnelle ou financière et ne fait aucune déclaration sur les fondamentaux de Magnite ; il se limite à divulguer l'intention de l'initié de vendre conformément à la règle 144.

Magnite, Inc. (MGNI) hat ein Formular 144 eingereicht, das einen geplanten Verkauf von 9.289 Stammaktien im Wert von etwa 204.358 $ zum aktuellen Marktpreis anzeigt. Die Aktien wurden ursprünglich am 15.02.2024 als eingeschränkte Aktien direkt vom Emittenten erworben und sollen etwa am 30.06.2025 über Morgan Stanley Smith Barney LLC verkauft werden. Die Gesamtzahl der ausstehenden Aktien beträgt 141.110.559, sodass der geplante Verkauf weniger als 0,01 % des Streubesitzes ausmacht.

Im Formular wird David Buonasera als verkaufender Aktionär genannt, der in den letzten drei Monaten bereits 12.395 Aktien für einen Bruttoerlös von 194.776,59 $ veräußert hat. Obwohl die Dollarbeträge im Verhältnis zur Marktkapitalisierung von Magnite gering sind, können aufeinanderfolgende Insider-Verkäufe bei einigen Investoren Bedenken hervorrufen. Das Formular enthält keine operativen oder finanziellen Leistungsdaten und macht keine Aussagen zu den Fundamentaldaten von Magnite; es offenbart lediglich die Verkaufsabsicht des Insiders gemäß Regel 144.

false 0001812360 0001812360 2025-06-30 2025-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date Earliest Event Reported): June 30, 2025

 

FOXO TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-39783   85-1050265

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

477 South Rosemary Avenue

Suite 224

West Palm Beach, FL

  33401
(Address of Principal Executive Offices)   (Zip Code)

 

(612) 800-0059

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, par value $0.0001   FOXO   NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 7.01 Regulation FD Disclosure.

 

On June 30, 2025, FOXO Technologies Inc., a Delaware corporation (the “Company”), issued a press release which announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has been approved to receive Scott County Opioid Abatement Funds for a second year, starting July 1, 2025 to provide care for uninsured patients from Scott County, at its Oneida, Tennessee location. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

The information under this Item 7.01, including Exhibit 99.1 hereto, is being furnished herewith and shall not be deemed “filed” for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibit hereto, is material or that the dissemination of such information is required by Regulation FD.

 

Cautionary Statement Regarding Forward-Looking Statements

 

This Current Report on Form 8-K contains “forward-looking statements.” Any statements contained in this Current Report on Form 8-K that do not describe historical facts may constitute forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “if,” “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. These forward-looking statements are based on information currently available to the Company’s management as well as estimates and assumptions made by its management and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause the Company’s or its industry’s actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. These forward-looking statements are made as of the date of this Current Report on Form 8-K, and the Company does not undertake an obligation to update these forward-looking statements after such date.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

Number

  Description of Exhibit
99.1   Press Release Dated June 30, 2025
104   Cover Page Interactive Data File (formatted in Inline XBRL)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  FOXO Technologies Inc.
     
Date: June 30, 2025 By: /s/ Seamus Lagan
  Name: Seamus Lagan
  Title: Chief Executive Officer

 

3

 

 

FAQ

What is Magnite (MGNI) disclosing in this Form 144?

The company reports an insider’s plan to sell 9,289 common shares worth about $204k on or after 06/30/2025.

Who is selling the shares according to the filing?

David Buonasera is listed as the selling shareholder under Rule 144.

How many Magnite shares has the insider sold recently?

The insider sold 12,395 shares in May 2025 and now plans to sell an additional 9,289 shares.

What percentage of Magnite’s outstanding shares does the planned sale represent?

Less than 0.01 % of the 141,110,559 shares outstanding.

Does the filing include any financial performance data?

No, Form 144 only details the intended sale; it contains no earnings or operational metrics.
FOXO TECHNOLOGIES

NYSE:FOXO

FOXO Rankings

FOXO Latest News

FOXO Latest SEC Filings

FOXO Stock Data

2.22M
10.43M
9.9%
2.69%
8%
Health Information Services
Services-commercial Physical & Biological Research
Link
United States
WEST PALM BEACH